학술논문
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): A phase II, open-label, multicenter, multinational cardiac safety study
Document Type
Article
Author
Source
In: Annals of Oncology . (Annals of Oncology, 1 March 2018, 29(3):646-653)
Subject
Language
English
ISSN
15698041
09237534
09237534